Gilder Gagnon Howe & CO LLC Denali Therapeutics Inc. Transaction History

Gilder Gagnon Howe & CO LLC

  • $7.87 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$15.83 - $23.35 $737,788 - $1.09 Million
-46,607 Reduced 3.82%
1,172,785 $24.1 Million
Q4 2023

Feb 14, 2024
SELL
$16.2 - $23.18 $434,273 - $621,386
-26,807 Reduced 2.15%
1,219,392 $26.2 Million
Q3 2023

Nov 14, 2023
SELL
$20.63 - $30.17 $6.89 Million - $10.1 Million
-333,746 Reduced 21.12%
1,246,199 $25.7 Million
Q2 2023

Aug 14, 2023
SELL
$23.37 - $32.96 $1.79 Million - $2.52 Million
-76,452 Reduced 4.62%
1,579,945 $46.6 Million
Q1 2023

May 15, 2023
SELL
$21.91 - $32.67 $2.43 Million - $3.62 Million
-110,745 Reduced 6.27%
1,656,397 $38.2 Million
Q4 2022

Feb 14, 2023
SELL
$26.28 - $33.92 $2.53 Million - $3.26 Million
-96,135 Reduced 5.16%
1,767,142 $49.1 Million
Q3 2022

Nov 14, 2022
SELL
$25.97 - $38.53 $2.43 Million - $3.6 Million
-93,543 Reduced 4.78%
1,863,277 $57.2 Million
Q2 2022

Aug 15, 2022
SELL
$20.88 - $35.19 $13.8 Million - $23.3 Million
-662,397 Reduced 25.29%
1,956,820 $57.6 Million
Q1 2022

May 16, 2022
SELL
$29.0 - $47.27 $8.15 Million - $13.3 Million
-280,897 Reduced 9.69%
2,619,217 $84.3 Million
Q4 2021

Feb 14, 2022
BUY
$42.59 - $55.02 $4.14 Million - $5.34 Million
97,120 Added 3.46%
2,900,114 $129 Million
Q3 2021

Nov 15, 2021
SELL
$48.48 - $78.23 $1.59 Million - $2.56 Million
-32,739 Reduced 1.15%
2,802,994 $141 Million
Q2 2021

Aug 16, 2021
SELL
$50.3 - $78.44 $8.49 Million - $13.2 Million
-168,820 Reduced 5.62%
2,835,733 $222 Million
Q1 2021

May 17, 2021
SELL
$53.8 - $81.53 $11.6 Million - $17.6 Million
-215,290 Reduced 6.69%
3,004,553 $172 Million
Q4 2020

Feb 16, 2021
SELL
$36.89 - $93.56 $3.55 Million - $9.01 Million
-96,287 Reduced 2.9%
3,219,843 $270 Million
Q3 2020

Nov 16, 2020
SELL
$23.13 - $38.84 $1.6 Million - $2.68 Million
-69,103 Reduced 2.04%
3,316,130 $119 Million
Q2 2020

Aug 14, 2020
BUY
$16.01 - $28.82 $1.99 Million - $3.58 Million
124,211 Added 3.81%
3,385,233 $81.9 Million
Q1 2020

May 15, 2020
BUY
$14.2 - $27.98 $46.3 Million - $91.2 Million
3,261,022 New
3,261,022 $57.1 Million
Q2 2019

Aug 13, 2019
SELL
$18.5 - $28.14 $11,026 - $16,771
-596 Closed
0 $0
Q1 2019

May 17, 2019
SELL
$17.99 - $24.65 $3,436 - $4,708
-191 Reduced 24.27%
596 $14,000
Q4 2018

Feb 14, 2019
SELL
$13.88 - $21.75 $166,851 - $261,456
-12,021 Reduced 93.86%
787 $16,000
Q3 2018

Oct 30, 2018
SELL
$12.46 - $21.74 $10,067 - $17,565
-808 Reduced 5.93%
12,808 $278,000
Q2 2018

Jul 31, 2018
SELL
$15.25 - $21.02 $1,021 - $1,408
-67 Reduced 0.49%
13,616 $208,000
Q1 2018

Apr 30, 2018
SELL
$15.36 - $24.8 $22,225 - $35,885
-1,447 Reduced 9.56%
13,683 $269,000
Q4 2017

Jan 31, 2018
BUY
$15.04 - $21.45 $227,555 - $324,538
15,130
15,130 $237,000

Others Institutions Holding DNLI

# of Institutions
227
Shares Held
119M
Call Options Held
60.6K
Put Options Held
48.4K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.88B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email